D-0557-2026 Class II Ongoing

Recalled by Guardian Drug Co. Inc. — Dayton, NJ

FDA drug recall D-0557-2026 was initiated by Guardian Drug Co. Inc. on May 28, 2026 and is designated Class II. Reason for recall: Presence of foreign substance: small metallic particles in chewable tablets. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2026
Initiation Date
May 28, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

KIRKLAND Signature, ULTRA STRENGTH ANTACID, Calcium Carbonate, 1000 mg, 265-count bottle, MANUFACTURED BY: GUARDIAN DRUG COMPANY, INC., 2 CHARLES COURT/DAYTON, NJ 08810, FOR: Costco Wholesale Corporation, 999 Lake Drive, Issaquah, WA 98027, NDC 63981-171-80

Reason for recall

Presence of foreign substance: small metallic particles in chewable tablets.

Distribution pattern

U.S.A. Nationwide

Code information

Lot#: 1716059, 1716060, 1716061, 1716062, 1716063, 1716218, 1716219, 1716228, 1716229, 1716238, Exp 2/28/2029; 1716258, Exp 3/31/2029.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0557-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0557-2026. Report a data issue: hello@regdatalab.com.